TY - JOUR AU - Legler, J. M. AU - Ries, L. A. AU - Smith, M. A. AU - Warren, J. L. AU - Heineman, E. F. AU - Kaplan, R. S. AU - Linet, M. S. PY - 1999 DA - 1999// TI - Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality JO - J Natl Cancer Inst VL - 91 UR - https://doi.org/10.1093/jnci/91.16.1382 DO - 10.1093/jnci/91.16.1382 ID - Legler1999 ER - TY - JOUR AU - Shrieve, D. C. AU - Alexander, E. AU - Black, P. M. AU - Wen, P. Y. AU - Fine, H. A. AU - Kooy, H. M. AU - Loeffler, J. S. PY - 1999 DA - 1999// TI - Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome JO - J Neurosurg VL - 90 UR - https://doi.org/10.3171/jns.1999.90.1.0072 DO - 10.3171/jns.1999.90.1.0072 ID - Shrieve1999 ER - TY - JOUR AU - Seegenschmiedt, M. H. AU - Karlsson, U. L. AU - Black, P. AU - Brady, L. W. PY - 1995 DA - 1995// TI - Thermoradiotherapy for brain tumors. Three cases of recurrent malignant astrocytoma and review of clinical experience JO - Am J Clin Oncol VL - 18 UR - https://doi.org/10.1097/00000421-199512000-00011 DO - 10.1097/00000421-199512000-00011 ID - Seegenschmiedt1995 ER - TY - JOUR AU - Fine, H. A. AU - Dear, K. B. AU - Loeffler, J. S. AU - Black, P. M. AU - Canellos, G. P. PY - 1993 DA - 1993// TI - Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults JO - Cancer VL - 71 UR - https://doi.org/3.0.CO;2-S DO - 3.0.CO;2-S ID - Fine1993 ER - TY - JOUR AU - Fumarola, C. AU - Guidotti, G. G. PY - 2004 DA - 2004// TI - Stress-induced apoptosis: toward a symmetry with receptor-mediated cell death JO - Apoptosis VL - 9 UR - https://doi.org/10.1023/B:APPT.0000012124.30095.09 DO - 10.1023/B:APPT.0000012124.30095.09 ID - Fumarola2004 ER - TY - JOUR AU - Lowe, S. W. AU - Schmitt, E. M. AU - Smith, S. W. AU - Osborne, B. A. AU - Jacks, T. PY - 1993 DA - 1993// TI - p53 is required for radiation-induced apoptosis in mouse thymocytes JO - Nature VL - 362 UR - https://doi.org/10.1038/362847a0 DO - 10.1038/362847a0 ID - Lowe1993 ER - TY - JOUR AU - Miyashita, T. AU - Reed, J. C. PY - 1995 DA - 1995// TI - Tumor suppressor p53 is a direct transcriptional activator of the human bax gene JO - Cell VL - 80 UR - https://doi.org/10.1016/0092-8674(95)90412-3 DO - 10.1016/0092-8674(95)90412-3 ID - Miyashita1995 ER - TY - JOUR AU - Vousden, K. H. AU - Lu, X. PY - 2002 DA - 2002// TI - Live or let die: the cell's response to p53 JO - Nat Rev Cancer VL - 2 UR - https://doi.org/10.1038/nrc864 DO - 10.1038/nrc864 ID - Vousden2002 ER - TY - JOUR AU - Oda, E. AU - Ohki, R. AU - Murasawa, H. AU - Nemoto, J. AU - Shibue, T. AU - Yamashita, T. AU - Tokino, T. AU - Taniguchi, T. AU - Tanaka, N. PY - 2000 DA - 2000// TI - Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis JO - Science VL - 288 UR - https://doi.org/10.1126/science.288.5468.1053 DO - 10.1126/science.288.5468.1053 ID - Oda2000 ER - TY - JOUR AU - Nakano, K. AU - Vousden, K. H. PY - 2001 DA - 2001// TI - PUMA, a novel proapoptotic gene, is induced by p53 JO - Mol Cell VL - 7 UR - https://doi.org/10.1016/S1097-2765(01)00214-3 DO - 10.1016/S1097-2765(01)00214-3 ID - Nakano2001 ER - TY - JOUR AU - Cory, S. AU - Adams, J. M. PY - 2002 DA - 2002// TI - The Bcl2 family: regulators of the cellular life-or-death switch JO - Nat Rev Cancer VL - 2 UR - https://doi.org/10.1038/nrc883 DO - 10.1038/nrc883 ID - Cory2002 ER - TY - JOUR AU - Kolesnick, R. AU - Fuks, Z. PY - 2003 DA - 2003// TI - Radiation and ceramide-induced apoptosis JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206702 DO - 10.1038/sj.onc.1206702 ID - Kolesnick2003 ER - TY - JOUR AU - von Haefen, C. AU - Wieder, T. AU - Gillissen, B. AU - Starck, L. AU - Graupner, V. AU - Dorken, B. AU - Daniel, P. T. PY - 2002 DA - 2002// TI - Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells JO - Oncogene VL - 21 UR - https://doi.org/10.1038/sj.onc.1205497 DO - 10.1038/sj.onc.1205497 ID - von Haefen2002 ER - TY - JOUR AU - Guner, D. AU - Belka, C. AU - Daniel, P. T. PY - 2003 DA - 2003// TI - Disruption of cell death signaling in cancer: impact on disease prognosis and response to therapy JO - Curr Med Chem Anti-Canc Agents VL - 3 UR - https://doi.org/10.2174/1568011033482369 DO - 10.2174/1568011033482369 ID - Guner2003 ER - TY - JOUR AU - Lammering, G. PY - 2003 DA - 2003// TI - Anti-epidermal growth factor receptor strategies to enhance radiation action JO - Curr Med Chem Anti-Canc Agents VL - 3 UR - https://doi.org/10.2174/1568011033482323 DO - 10.2174/1568011033482323 ID - Lammering2003 ER - TY - JOUR AU - Li, J. AU - Yen, C. AU - Liaw, D. AU - Podsypanina, K. AU - Bose, S. AU - Wang, S. I. AU - Puc, J. AU - Miliaresis, C. AU - Rodgers, L. AU - McCombie, R. AU - Bigner, S. H. AU - Giovanella, B. C. AU - Ittmann, M. AU - Tycko, B. AU - Hibshoosh, H. AU - Wigler, M. H. AU - Parsons, R. PY - 1997 DA - 1997// TI - PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer JO - Science VL - 275 UR - https://doi.org/10.1126/science.275.5308.1943 DO - 10.1126/science.275.5308.1943 ID - Li1997 ER - TY - JOUR AU - Haas-Kogan, D. AU - Shalev, N. AU - Wong, M. AU - Mills, G. AU - Yount, G. AU - Stokoe, D. PY - 1998 DA - 1998// TI - Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC JO - Curr Biol VL - 8 UR - https://doi.org/10.1016/S0960-9822(07)00493-9 DO - 10.1016/S0960-9822(07)00493-9 ID - Haas-Kogan1998 ER - TY - JOUR AU - Maher, E. A. AU - Furnari, F. B. AU - Bachoo, R. M. AU - Rowitch, D. H. AU - Louis, D. N. AU - Cavenee, W. K. AU - DePinho, R. A. PY - 2001 DA - 2001// TI - Malignant glioma: genetics and biology of a grave matter JO - Genes Dev VL - 15 UR - https://doi.org/10.1101/gad.891601 DO - 10.1101/gad.891601 ID - Maher2001 ER - TY - JOUR AU - Belka, C. AU - Jendrossek, V. AU - Pruschy, M. AU - Vink, S. AU - Verheij, M. AU - Budach, W. PY - 2004 DA - 2004// TI - Apoptosis-modulating agents in combination with radiotherapy-current status and outlook JO - Int J Radiat Oncol Biol Phys VL - 58 UR - https://doi.org/10.1016/j.ijrobp.2003.09.067 DO - 10.1016/j.ijrobp.2003.09.067 ID - Belka2004 ER - TY - JOUR AU - Jendrossek, V. AU - Handrick, R. PY - 2003 DA - 2003// TI - Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitizers JO - Curr Med Chem Anti-Cancer Agents VL - 3 UR - https://doi.org/10.2174/1568011033482341 DO - 10.2174/1568011033482341 ID - Jendrossek2003 ER - TY - JOUR AU - Houlihan, W. J. AU - Lohmeyer, M. AU - Workman, P. AU - Cheon, S. H. PY - 1995 DA - 1995// TI - Phospholipid antitumor agents JO - Med Res Rev VL - 15 UR - https://doi.org/10.1002/med.2610150302 DO - 10.1002/med.2610150302 ID - Houlihan1995 ER - TY - JOUR AU - Berkovic, D. AU - Grundel, O. AU - Berkovic, K. AU - Wildfang, I. AU - Hess, C. F. AU - Schmoll, H. J. PY - 1997 DA - 1997// TI - Synergistic cytotoxic effects of ether phospholipid analogues and ionizing radiation in human carcinoma cells JO - Radiother Oncol VL - 43 UR - https://doi.org/10.1016/S0167-8140(97)01909-9 DO - 10.1016/S0167-8140(97)01909-9 ID - Berkovic1997 ER - TY - JOUR AU - Georgieva, M. C. AU - Konstantinov, S. M. AU - Topashka-Ancheva, M. AU - Berger, M. R. PY - 2002 DA - 2002// TI - Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells JO - Cancer Lett VL - 182 UR - https://doi.org/10.1016/S0304-3835(02)00088-5 DO - 10.1016/S0304-3835(02)00088-5 ID - Georgieva2002 ER - TY - JOUR AU - Jendrossek, V. AU - Kugler, W. AU - Erdlenbruch, B. AU - Eibl, H. AU - Lang, F. AU - Lakomek, M. PY - 2001 DA - 2001// TI - Erucylphosphocholine-induced apoptosis in chemoresistant glioblastoma cell lines: involvement of caspase activation and mitochondrial alterations JO - Anticancer Res VL - 21 ID - Jendrossek2001 ER - TY - JOUR AU - Ruiter, G. A. AU - Verheij, M. AU - Zerp, S. F. AU - van Blitterswijk, W. J. PY - 2001 DA - 2001// TI - Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis JO - Int J Radiat Oncol Biol Phys VL - 49 UR - https://doi.org/10.1016/S0360-3016(00)01476-0 DO - 10.1016/S0360-3016(00)01476-0 ID - Ruiter2001 ER - TY - JOUR AU - Stekar, J. AU - Hilgard, P. AU - Klenner, T. PY - 1995 DA - 1995// TI - Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamide JO - Eur J Cancer VL - 31A UR - https://doi.org/10.1016/0959-8049(94)00495-Q DO - 10.1016/0959-8049(94)00495-Q ID - Stekar1995 ER - TY - JOUR AU - Bruyneel, E. A. AU - Storme, G. A. AU - Schallier, D. C. AU - Van den Berge, D. L. AU - Hilgard, P. AU - Mareel, M. M. PY - 1993 DA - 1993// TI - Evidence for abrogation of oncogene-induced radioresistance of mammary cancer cells by hexadecylphosphocholine in vitro JO - Eur J Cancer VL - 29A UR - https://doi.org/10.1016/0959-8049(93)90452-L DO - 10.1016/0959-8049(93)90452-L ID - Bruyneel1993 ER - TY - JOUR AU - Ruiter, G. A. AU - Zerp, S. F. AU - Bartelink, H. AU - van Blitterswijk, W. J. AU - Verheij, M. PY - 1999 DA - 1999// TI - Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis JO - Cancer Res VL - 59 ID - Ruiter1999 ER - TY - JOUR AU - Jendrossek, V. AU - Erdlenbruch, B. AU - Hunold, A. AU - Kugler, W. AU - Eibl, H. AU - Lakomek, M. PY - 1999 DA - 1999// TI - Erucylphosphocholine, a novel antineoplastic ether lipid, blocks growth and induces apoptosis in brain tumor cell lines in vitro JO - Int J Oncol VL - 14 ID - Jendrossek1999 ER - TY - JOUR AU - Jendrossek, V. AU - Hammersen, K. AU - Erdlenbruch, B. AU - Kugler, W. AU - Krugener, R. AU - Eibl, H. AU - Lakomek, M. PY - 2002 DA - 2002// TI - Structure-activity relationships of alkylphosphocholine derivatives: antineoplastic action on brain tumor cell lines in vitro JO - Cancer Chemother Pharmacol VL - 50 UR - https://doi.org/10.1007/s00280-002-0440-8 DO - 10.1007/s00280-002-0440-8 ID - Jendrossek2002 ER - TY - JOUR AU - Erdlenbruch, B. AU - Jendrossek, V. AU - Gerriets, A. AU - Vetterlein, F. AU - Eibl, H. AU - Lakomek, M. PY - 1999 DA - 1999// TI - Erucylphosphocholine: pharmacokinetics, biodistribution and CNS-accumulation in the rat after intravenous administration JO - Cancer Chemother Pharmacol VL - 44 UR - https://doi.org/10.1007/s002800051122 DO - 10.1007/s002800051122 ID - Erdlenbruch1999 ER - TY - JOUR AU - Erdlenbruch, B. AU - Jendrossek, V. AU - Kugler, W. AU - Eibl, H. AU - Lakomek, M. PY - 2002 DA - 2002// TI - Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats JO - Cancer Chemother Pharmacol VL - 50 UR - https://doi.org/10.1007/s00280-002-0497-4 DO - 10.1007/s00280-002-0497-4 ID - Erdlenbruch2002 ER - TY - JOUR AU - Jendrossek, V. AU - Muller, I. AU - Eibl, H. AU - Belka, C. PY - 2003 DA - 2003// TI - Intracellular mediators of erucylphosphocholine-induced apoptosis JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206355 DO - 10.1038/sj.onc.1206355 ID - Jendrossek2003 ER - TY - JOUR AU - Belka, C. AU - Budach, W. PY - 2002 DA - 2002// TI - Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology JO - Int J Radiat Biol VL - 78 UR - https://doi.org/10.1080/09553000210137680 DO - 10.1080/09553000210137680 ID - Belka2002 ER - TY - JOUR AU - Brown, J. M. AU - Wouters, B. G. PY - 1999 DA - 1999// TI - Apoptosis, p53, and tumor cell sensitivity to anticancer agents JO - Cancer Res VL - 59 ID - Brown1999 ER - TY - JOUR AU - Belka, C. AU - Schmid, B. AU - Marini, P. AU - Durand, E. AU - Rudner, J. AU - Faltin, H. AU - Bamberg, M. AU - Schulze-Osthoff, K. AU - Budach, W. PY - 2001 DA - 2001// TI - Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL JO - Oncogene VL - 20 UR - https://doi.org/10.1038/sj.onc.1204318 DO - 10.1038/sj.onc.1204318 ID - Belka2001 ER - TY - JOUR AU - Marini, P. AU - Schmid, A. AU - Jendrossek, V. AU - Faltin, H. AU - Daniel, P. T. AU - Budach, W. AU - Belka, C. PY - 2005 DA - 2005// TI - Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis JO - BMC Cancer VL - 5 UR - https://doi.org/10.1186/1471-2407-5-5 DO - 10.1186/1471-2407-5-5 ID - Marini2005 ER - TY - JOUR AU - Tenzer, A. AU - Zingg, D. AU - Rocha, S. AU - Hemmings, B. AU - Fabbro, D. AU - Glanzmann, C. AU - Schubiger, P. A. AU - Bodis, S. AU - Pruschy, M. PY - 2001 DA - 2001// TI - The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C JO - Cancer Res VL - 61 ID - Tenzer2001 ER - TY - JOUR AU - Magistrelli, A. AU - Villa, P. AU - Benfenati, E. AU - Modest, E. J. AU - Salmona, M. AU - Tacconi, M. T. PY - 1995 DA - 1995// TI - Fate of 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET18-OME) in malignant cells, normal cells, and isolated and perfused rat liver JO - Drug Metab Dispos VL - 23 ID - Magistrelli1995 ER - TY - JOUR AU - Unger, C. AU - Sindermann, H. AU - Peukert, M. AU - Hilgard, P. AU - Engel, J. AU - Eibl, H. PY - 1992 DA - 1992// TI - Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients JO - Prog Exp Tumor Res VL - 34 UR - https://doi.org/10.1159/000420840 DO - 10.1159/000420840 ID - Unger1992 ER - TY - JOUR AU - Clive, S. AU - Gardiner, J. AU - Leonard, R. C. PY - 1999 DA - 1999// TI - Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma JO - Cancer Chemother Pharmacol VL - 44 Suppl UR - https://doi.org/10.1007/s002800051114 DO - 10.1007/s002800051114 ID - Clive1999 ER - TY - JOUR AU - Smorenburg, C. H. AU - Seynaeve, C. AU - Bontenbal, M. AU - Planting, A. S. AU - Sindermann, H. AU - Verweij, J. PY - 2000 DA - 2000// TI - Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients JO - Anticancer Drugs VL - 11 UR - https://doi.org/10.1097/00001813-200011000-00006 DO - 10.1097/00001813-200011000-00006 ID - Smorenburg2000 ER - TY - JOUR AU - Dummer, R. AU - Krasovec, M. AU - Roger, J. AU - Sindermann, H. AU - Burg, G. PY - 1993 DA - 1993// TI - Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study JO - J Am Acad Dermatol VL - 29 UR - https://doi.org/10.1016/0190-9622(93)70275-X DO - 10.1016/0190-9622(93)70275-X ID - Dummer1993 ER - TY - JOUR AU - Leonard, R. AU - Hardy, J. AU - van Tienhoven, G. AU - Houston, S. AU - Simmonds, P. AU - David, M. AU - Mansi, J. PY - 2001 DA - 2001// TI - Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer JO - J Clin Oncol VL - 19 ID - Leonard2001 ER - TY - JOUR AU - Sundar, S. AU - Jha, T. K. AU - Thakur, C. P. AU - Engel, J. AU - Sindermann, H. AU - Fischer, C. AU - Junge, K. AU - Bryceson, A. AU - Berman, J. PY - 2002 DA - 2002// TI - Oral miltefosine for Indian visceral leishmaniasis JO - N Engl J Med VL - 347 UR - https://doi.org/10.1056/NEJMoa021556 DO - 10.1056/NEJMoa021556 ID - Sundar2002 ER - TY - JOUR AU - Hilgard, P. AU - Klenner, T. AU - Stekar, J. AU - Nossner, G. AU - Kutscher, B. AU - Engel, J. PY - 1997 DA - 1997// TI - D-21266, a new heterocyclic alkylphospholipid with antitumour activity JO - Eur J Cancer VL - 33 UR - https://doi.org/10.1016/S0959-8049(97)89020-X DO - 10.1016/S0959-8049(97)89020-X ID - Hilgard1997 ER - TY - JOUR AU - Van Ummersen, L. AU - Binger, K. AU - Volkman, J. AU - Marnocha, R. AU - Tutsch, K. AU - Kolesar, J. AU - Arzoomanian, R. AU - Alberti, D. AU - Wilding, G. PY - 2004 DA - 2004// TI - A phase I trial of perifosine (NSC 639966) on a loading dose/maintenance dose schedule in patients with advanced cancer JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-03-0406 DO - 10.1158/1078-0432.CCR-03-0406 ID - Van Ummersen2004 ER - TY - JOUR AU - Crul, M. AU - Rosing, H. AU - de Klerk, G. J. AU - Dubbelman, R. AU - Traiser, M. AU - Reichert, S. AU - Knebel, N. G. AU - Schellens, J. H. AU - Beijnen, J. H. AU - ten Bokkel Huinink, W. W. PY - 2002 DA - 2002// TI - Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours JO - Eur J Cancer VL - 38 UR - https://doi.org/10.1016/S0959-8049(02)00127-2 DO - 10.1016/S0959-8049(02)00127-2 ID - Crul2002 ER - TY - STD TI - Posadas EM, Gulley J, Arlen PM, Trout A, Parnes HL, Wright J, Lee MJ, Chung EJ, Trepel JB, Sparreboom A, Chen C, Jones E, Steinberg SM, Daniels A, Figg WD, Dahut WL: A Phase II Study of Perifosine in Androgen Independent Prostate Cancer.Cancer Biol Ther 2005.,4(10): ID - ref49 ER - TY - CHAP AU - Ernst, D. S. AU - Eisenhauer, E. AU - Wainman, N. AU - Davis, M. AU - Lohmann, R. AU - Baetz, T. AU - Belanger, K. AU - Smylie, M. PY - 2005 DA - 2005// TI - Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma BT - Invest New Drugs ID - Ernst2005 ER - TY - JOUR AU - Konstantinov, S. M. AU - Berger, M. R. PY - 1999 DA - 1999// TI - Human urinary bladder carcinoma cell lines respond to treatment with alkylphosphocholines JO - Cancer Lett VL - 144 UR - https://doi.org/10.1016/S0304-3835(99)00219-0 DO - 10.1016/S0304-3835(99)00219-0 ID - Konstantinov1999 ER - TY - JOUR AU - Berenbaum, M. C. PY - 1978 DA - 1978// TI - A method for testing for synergy with any number of agents JO - J Infect Dis VL - 137 UR - https://doi.org/10.1093/infdis/137.2.122 DO - 10.1093/infdis/137.2.122 ID - Berenbaum1978 ER -